Hepatitis C Journal Articles

• HCC 10+ Years After Viral Eradication in Patients With HCV What risk factors are associated with hepatocellular carcinoma development 10 years or more after SVR?
  Journal of Viral Hepatitis, October 07, 2022
• Severe and Rare Infections Among Adults With Psoriasis This study found that as the severity of psoriasis increases, so does the risk of severe and rare infections.
  The British Journal of Dermatology, October 07, 2022
• IVF-ET and Mother-to-infant Transmission in Women With HBV Does in vitro fertilization-embryo transfer increase the risk of mother-to-child transmission of hepatitis B virus?
  Liver International, October 05, 2022
• Viral Hepatitis in Pregnancy This review presents a summary of the etiology and epidemiology of the five hepatitis viruses with a focus on their immunopathogenic effects in pregnancy.
  Journal of Viral Hepatitis, September 30, 2022
• Final Safety and Efficacy of an Ascites-mobilizing Pump This study investigated the safety and efficacy of an implantable device mobilizing ascites from the peritoneal cavity to the bladder in a real-world cohort with cirrhotic refractory ascites.
  Liver International, September 21, 2022
• NAFLD Fibrosis Scores Predict Liver-related HCV Complications This study evaluated the use of noninvasive fibrosis assessments for predicting liver-related complications and hepatocellular carcinoma occurrence in patients with chronic HCV receiving DAA therapy.
  Journal of Viral Hepatitis, September 20, 2022
• Universal HBV Vaccination Reduces HBV Infection and HCC This real-life cohort study of nearly 700,000 individuals reveals that universal HBV vaccination of newborns significantly reduced the prevalence of chronic HBV infection later in life.
  Alimentary Pharmacology & Therapeutics, September 14, 2022
• NAFLD and Liver Fibrosis Increase Cardiovascular Risk in HIV Are people living with HIV with NAFLD and/or liver fibrosis at a greater risk for cardiovascular disease? A new study explores the potential link.
  HIV Medicine, September 14, 2022
• Symptom Improvement: LDV/SOF vs. EBR/GZR for Chronic HCV This study found that regimens of EBR/GZR or LDV/SOF for chronic HCV had no clinically meaningful differences in improvement of symptoms and functional well-being.
  Journal of Viral Hepatitis, September 13, 2022
• Bicyclol for Idiosyncratic Acute Drug-induced Liver Injury This study evaluated different dosing regimens of the novel synthetic anti-hepatitis drug bicyclol for treating drug-induced liver injury.
  Liver International, September 13, 2022
• Hypertension in HIV Treated With INSTIs vs Other Regimens How common is hypertension among HIV patients receiving INSTI-based ART compared with those treated with other ART regimens?
  HIV Medicine, September 07, 2022
• Follow-up of Liver Test Abnormalities Detected During SARS-CoV2 Do abnormal liver function tests noted during COVID-19 persist after resolution of the acute infection?
  Journal of Viral Hepatitis, September 06, 2022
• TDF Therapy to Prevent HBV Vertical Transmission This study investigated the efficacy and safety of tenofovir disoproxil fumarate administration to prevent HBV mother-to-child transmission
  Liver International, September 06, 2022
• Delivery Methods of DAAs for HCV in People Who Inject Drugs This study compared different dispensing methods of DAAs for HCV treatment in people who inject drugs. Can DAAs be dispensed every two weeks instead of with daily directly observed therapy?
  Journal of Viral Hepatitis, August 30, 2022
• HCV Infection Associated With Hospital-based Invasive Procedures How great is the risk of HCV transmission from hospital-based invasive procedures? This study examine which invasive procedures were significantly associated with HCV infection.
  Alimentary Pharmacology & Therapeutics, August 29, 2022
• HBV Status and GDM Prevalence Among Pregnant Women With HBV How does different status of HBV infection impact the prevalence of gestational diabetes mellitus in pregnant women?
  Journal of Viral Hepatitis, August 26, 2022
• Factors Partitioning Frailty in People Aging With HIV A new study helps further our understanding of the factors involved in the development and progression of frailty among older adults living with HIV.
  HIV Medicine, August 24, 2022
• Outcome of Liver Cancer Patients With SARS-CoV-2 Infection This study characterizes the 30-day mortality risk of SARS-CoV-2 infected patients with hepatocellular carcinoma.
  Liver International, August 23, 2022
• HCV Micro-Elimination Within a Clinic for People With HIV This article highlights the challenges that remain in reaching HCV micro-elimination among people living with HIV.
  HIV Medicine, August 17, 2022
• Closing the HCV Treatment Gap: Improving Retention in Care In this paper, the authors identify barriers in HCV care retention and propose solutions to increase HCV treatment delivery.
  Journal of Viral Hepatitis, August 16, 2022